The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects. (Q34786832)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12182961%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

review article

1 reference

title

The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12182961%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12182961%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Isabel Lastres-Becker

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12182961%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

Rosario de Miguel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12182961%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Fernando Berrendero

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12182961%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

José A Ramos

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12182961%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Javier Fernández-Ruiz

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12182961%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 August 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12182961%20AND%20SRC:MED&resulttype=core&format=json

Pharmacology & Therapeutics

12 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12182961%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12182961%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

137-152

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12182961%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12182961%20AND%20SRC:MED&resulttype=core&format=json

(R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

3-Nitropropionic acid's lethal triplet: cooperative pathways of neurodegeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

The cannabinoid agonists WIN 55,212-2 and CP 55,940 attenuate rotational behavior induced by a dopamine D1 but not a D2 agonist in rats with unilateral lesions of the nigrostriatal pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

The cloned rat hydrolytic enzyme responsible for the breakdown of anandamide also catalyzes its formation via the condensation of arachidonic acid and ethanolamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Cannabinoids control spasticity and tremor in a multiple sclerosis model

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Selective blockade of type-1 metabotropic glutamate receptors induces neuroprotection by enhancing gabaergic transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Aging, energy, and oxidative stress in neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

HU-211, a nonpsychotropic cannabinoid, improves neurological signs and reduces brain damage after severe forebrain ischemia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Functional role of high-affinity anandamide transport, as revealed by selective inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Long-term electrical inhibition of deep brain targets in movement disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Changes in cannabinoid receptor binding and mRNA levels in several brain regions of aged rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Functional changes of the basal ganglia circuitry in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Adjuncts to dopamine replacement: a pragmatic approach to reducing the problem of dyskinesia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Presynaptic inhibition of GABAergic inputs to rat substantia nigra pars reticulata neurones by a cannabinoid agonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Brain cannabinoid systems as targets for the therapy of neurological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Regressive events in neurogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington's disease mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Enhancement of Anandamide Formation in the Limbic Forebrain and Reduction of Endocannabinoid Contents in the Striatum of Δ9-Tetrahydrocannabinol-Tolerant Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Cannabinoid receptors and their endogenous agonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Role of endocannabinoids in brain development

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

The endogenous cannabinoid system and brain development

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Neurotransmitters and second messengers in aging and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374)

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Dopamine activation of endogenous cannabinoid signaling in dorsal striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Loss of cannabinoid receptors in the substantia nigra in Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

The CB1 cannabinoid receptor antagonist SR 141716A affects A9 dopamine neuronal activity in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Cannabinoids, hippocampal function and memory

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Putative neuroprotective actions of N-acyl-ethanolamines

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Characterization of cannabinoid receptors coupled to vasorelaxation by endothelium-derived hyperpolarizing factor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Effective treatment of Tourette's syndrome with marijuana.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Cannabinoid receptor localization in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Neuronal localization of cannabinoid receptors in the basal ganglia of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Cannabinol and cannabidiol in combination: temperature, open-field activity, and vocalization

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Pharmacology of cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

The cannabinoid receptor: biochemical, anatomical and behavioral characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Regulation of the cAMP cascade, gene expression and immune function by cannabinoid receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Dopaminergic regulation of cannabinoid receptor mRNA levels in the rat caudate-putamen: an in situ hybridization study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Glutamatergic regulation of cannabinoid receptor gene expression in the caudate-putamen.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Activation of the cannabinoid receptor by delta 9-tetrahydrocannabinol reduces gamma-aminobutyric acid uptake in the globus pallidus.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

The cannabinoid receptor agonist WIN 55,212-2 reduces D2, but not D1, dopamine receptor-mediated alleviation of akinesia in the reserpine-treated rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Fine motor control in rats is disrupted by delta-9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Search for endogenous ligands of the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Effects of a cannabinoid on spontaneous and evoked neuronal activity in the substantia nigra pars reticulata

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Electrophysiological effects of a cannabinoid on neural activity in the globus pallidus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Ipsilateral turning behavior induced by unilateral microinjections of a cannabinoid into the rat subthalamic nucleus.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Tetrahydrocannabinol potentiates reserpine-induced hypokinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Cannabinoids: possible role in patho-physiology and therapy of Gilles de la Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Nabilone increases choreatic movements in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Motor disturbances induced by an acute dose of delta 9-tetrahydrocannabinol: possible involvement of nigrostriatal dopaminergic alterations.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Effects of systemic 3-nitropropionic acid-induced lesions of the dorsal striatum on cannabinoid and mu-opioid receptor binding in the basal ganglia.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Presence and functional regulation of cannabinoid receptors in immune cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Pharmacology of cannabinoid CB1 and CB2 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Cannabinoids and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Drugs which stimulate or facilitate central GABAergic transmission interact synergistically with delta-9-tetrahydrocannabinol to produce marked catalepsy in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

O-1057, a potent water-soluble cannabinoid receptor agonist with antinociceptive properties

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Structural determinants for recognition and translocation by the anandamide transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Cardiovascular effects of cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Recent advances in understanding the pathogenesis of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

The subthalamic nucleus and tremor in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Extrapyramidal effects of methanandamide, an analog of anandamide, the endogenous CB1 receptor ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [35S]guanylyl-5'O-(thio)-triphosphate binding in the basal ganglia of aged rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased CB1 receptor mRNA levels in the caudate-putamen

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Delayed transneuronal death of substantia nigra neurons prevented by gamma-aminobutyric acid agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Prevention of transneuronal degeneration of neurons in the substantia nigra reticulata by ablation of the subthalamic nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Role of the subthalamic nucleus in cannabinoid actions in the substantia nigra of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Effects of intranigral cannabinoids on rotational behavior in rats: interactions with the dopaminergic system.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Cannabinoid effects in basal ganglia in a rat model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Motor actions of cannabinoids in the basal ganglia output nuclei

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Activational role of cannabinoids on movement

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Striatal cannabinoid CB1 receptor mRNA expression is decreased in the reserpine-treated rat model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Differential association between chronic cannabis use and brain function deficits

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Intrastriatal injection of cannabinoid receptor agonists induced turning behavior in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Local pressure application of cannabinoid agonists increases spontaneous activity of rat substantia nigra pars reticulata neurons without affecting response to iontophoretically-applied GABA.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Physical withdrawal in rats tolerant to delta 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Neuropathological classification of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Cardiovascular actions of cannabinoids and their generation during shock

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

The neurobiology of cannabinoid analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

delta 9-Tetrahydrocannabinol and anandamide enhance the ability of muscimol to induce catalepsy in the globus pallidus of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Current cannabis use and tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Chronic L-DOPA treatment increases striatal cannabinoid CB1 receptor mRNA expression in 6-hydroxydopamine-lesioned rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

The anandamide transport inhibitor AM404 activates vanilloid receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2802%2900253-X

7 January 2021

10.1016/S0163-7258(02)00253-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12182961%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference